Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
artience, formerly known as the Toyo Ink Group, is a global specialty chemicals company that has established a significant presence in the life sciences and healthcare sectors. The company leverages its core expertise in polymer synthesis and dispersion technologies to develop advanced medical materials, specifically focusing on transdermal drug delivery systems (TDDS) and medical-grade adhesives. Through its subsidiary Toyochem, artience operates as a CDMO, providing integrated support from formulation design to the manufacturing of pharmaceutical patches and tapes. Additionally, the company produces high-performance materials for the life sciences, including fluorescent probes for bio-imaging and diagnostic reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toyo Ink Group.